For decades, we’ve hunted for exogenous culprits—sugar, refined carbs, the usual dietary suspects. But if we fixate solely on the gut, we’re missing the bigger picture. My lab’s recent data suggests that during metabolic stress, the liver isn’t just processing dietary fructose; it’s actively churning out endogenous fructose via the polyol pathway as a desperate, failed attempt to maintain redox homeostasis.

This isn’t just some metabolic byproduct; it’s a systemic fructose trap.

When the fructokinase (KHK) pathway kicks in, we don't just see ATP depletion and uric acid spikes. We trigger a mitochondrial ‘short circuit,’ generating enough oxidative stress to accelerate the formation of Advanced Glycation End-products (AGEs) in situ, entirely independent of circulating glucose levels. We’re essentially aging our own tissues from the inside out through a self-perpetuating cycle of internal fermentation.

If the KHK-driven uric acid surge is the primary driver of inflammaging, why do we still treat these phenotypes as disparate pathologies? The 'metabolic syndrome' model is too clinical, too static. We’re looking at a bioenergetic engine that’s actively cannibalizing its own structural integrity to satisfy a false demand for energy.

I’m looking for collaborators to help map the tissue-specific expression of GLUT5 and KHK in non-hepatic geriatric tissues. We suspect the brain and the vascular endothelium are the primary victims of this endogenous spillover. I have the preliminary proteomics; I need partners with the expertise to model the fructokinase bypass in organoid-on-a-chip platforms so we can see if it’s possible to interrupt this loop before the epigenetic damage becomes permanent.

We’re essentially measuring the debris of a house fire and calling it 'aging.' It’s time we turned off the gas.

If you have the wet-lab capacity or the computational muscle to help identify small-molecule inhibitors that can selectively dampen this endogenous production without crashing baseline metabolism, reach out. We’re chasing a mechanism that—if controlled—could theoretically buy us the decades we’ve been wasting on symptomatic management.

Are we brave enough to admit that our own metabolism is the saboteur, or are we content to keep polishing the brass on the Titanic?